NCT07246187
- Conditions
- Cannabinoid Hyperemesis Syndrome, Chemically-Induced Disorders, Marijuana Abuse, +2 more
- Locations
-
- Mercy Saint Vincent Medical Center Toledo, Ohio, United States
Clinical trial condition
Marijuana Abuse
Explore clinical trials studying Marijuana Abuse. Study availability and eligibility vary by location and protocol.
5 public trials
1 recruiting study
Marijuana Abuse trial results
Enrolling by Invitation
Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls
NCT05812339
- Conditions
- Cannabinoid Hyperemesis Syndrome, Chemically-Induced Disorders, Cyclical Vomiting, +15 more
- Locations
-
- University of Calgary Calgary, Alberta, Canada
Not Yet Recruiting
Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency Department
NCT07726069
- Conditions
- Albinism, Cannabinoid Hyperemesis Syndrome, Chediak-Higashi Syndrome, +15 more
- Locations
-
- University of Illinois Hospital Chicago, Illinois, United States
NCT04283292
- Conditions
- Cannabinoid Hyperemesis Syndrome, Chemically-Induced Disorders, Marijuana Abuse, +2 more
- Locations
-
- UVA Health System Charlottesville, Virginia, United States
Completed
Treatment Strategies in CHS
NCT04176055
- Conditions
- Cannabinoid Hyperemesis Syndrome, Cannabis Hyperemesis Syndrome, Chemically-Induced Disorders, +3 more
- Locations
-
- University of Calgary Calgary, Alberta, Canada